TOP PICK
McKesson Corp

Global leader. Operates in a virtual tri-opoly. Significant leverage in negotiating supply, which gives predictable cashflow. Aging population will increase volumes. Almost 60% of all Americans use at least 1 prescription drug, expected to rise. Increased demand for diabetes and weigh-loss drugs. 

Beat on top and bottom lines, increased guidance. Share price above rising moving averages. Outperforming broader index. Forecast 10% earnings growth going forward. Yield is 0.55%.

(Analysts’ price target is $487.63)
wholesale distributors
BUY
McKesson Corp

Though drug companies are a target of politicians citing high drug prices, it keeps printing cash. For now, it's a cheap stock that won't be hurt by higher interest rates.

wholesale distributors
PAST TOP PICK
McKesson Corp
(A Top Pick Oct 28/22, Up 11%)

Still likes it. The drug sector remains strong given an aging population and a flurry of new drugs.

wholesale distributors
PAST TOP PICK
McKesson Corp
(A Top Pick Sep 09/22, Up 21%)

One of the largest distributors of pharmaceuticals in USA.
Expecting to grow earnings 12-15% annual.
Trading at good share price for long term investors.
Beneficiary of domestic spending. 
Will continue to hold. 

wholesale distributors
TOP PICK
McKesson Corp

Earnings are growing about 12-14% per year, revenues over 10%. Trades about 15x earnings. Exited European operations, so now a pure play on a domestic company and a hedge against international exposure. Yield is 0.59%.

(Analysts’ price target is $468.64)
wholesale distributors
TOP PICK
McKesson Corp
Large drug distributor with 1/3 drug distribution business in USA. Excellent prospects going forward with strong R & D potential. Main company for US government for items like Covid-19 vaccines. Demand for new drugs will not go away. Expecting growth of dividend.
wholesale distributors
BUY
McKesson Corp
New entry into portfolio. One of three main pharmaceutical distributors. Trading at 15x multiple of earnings. Growing at 10% per year. Have existed to European business (good for US dollar exposure).
wholesale distributors
DON'T BUY
McKesson Corp
Political lightning rod of distributors, so he's on the sidelines. Windfalls from Covid vaccine distribution, but this will dissipate. Price, time, volume are subject to inflationary pressures.
wholesale distributors
COMMENT
McKesson Corp
Peer Amerisource missed their report today and analysts may downgrade the entire group, which trades together. MCK is best in class, but let's see what happens tomorrow with downgrades.
wholesale distributors
BUY
McKesson Corp
A Covid vaccine distribution play It's the biggest and best-run drug distributor. They were instrumental in getting out the swine flu vaccine. Trades at 10x at 2021's estimates. Has a lot of room to run. MCK is part of an oligopoly in this industry and it's the best choice within this oligopoly. MCK has distributed for the CDC before, so they have a track record.
wholesale distributors
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

PAST TOP PICK
McKesson Corp
(A Top Pick Aug 04/20, Down 7.7%)Stockchase Research Editor: Michael O'Reilly We are recommending to cover MCK as it has violated our stop-loss. We are being disciplined and will look for better opportunties.
wholesale distributors
premium

This is a Panic-proof Portfolio opinion which is available only for Premium members

Curated by Michael O'Reilly since 2020.
1550+ opinions with 4.81 rating (one of the best performing expert).

TOP PICK
McKesson Corp
Stockchase Research Editor: Michael O'Reilly The company produces and distributes medical devices in the US and internationally. They are also involved in pharma distribution and community based oncology and other specialty practices. Although there was a slight slowdown in Q1 earnings growth due to the pandemic shutdowns, earnings and revenues still beat expectation. Although the dividend is not huge, it is growing -- up 250% since 2008 -- and the payout ratio is less than 35%. We like the technical setup presently and see a buy here as having upside towards $175 -- 11% upside. We would use $145 as a stop loss. Yield 1.05% (Analysts’ price target is $174.20)
wholesale distributors
DON'T BUY
McKesson Corp
Not a big fan of the drug distributors. Generics pricing headwind, costs, political overhang, there is a number of fundamental flags for them. He would stay away from this. They don't buy declining charts. They want to see strong fundamentals confirmed by positive price action. Loves healthcare but prefers a broad basket of healthcare funds. Biotechs are a little weaker but devices and managed care are fantastic. Healthcare will underperform, but still go up, they like that kind of quality trade in a market that they are a little suspect of.
wholesale distributors
COMMENT
McKesson Corp
He exited. They distribute drugs, a price x volume business, with retail pharmacy (Rexall) outlets in Canada as well as another chain in Germany. The stock is cheap, but the overall business is in the process of changing as the discussion in the States shifts from high drug prices to rebates. That's why he's on the sidelines of the drug distributors. Also, branded drug prices are rising 6-8%, but generics are falling 8-10% annually--that's begative. He's on the sidelines of this sector. Keep an eye on generic pricing.
wholesale distributors
DON'T BUY
McKesson Corp

This has been a very successful operation. The 5th largest corporation in the US, and doing extremely well. 60 Minutes recently did a profile on their distribution of opioids to pharmacies/dispensaries where the DVA thought they should have known there were some orders that were not legitimate and were going to cartels and illegal drug distribution networks. He thinks this has some legs, so he would not venture into this company.

wholesale distributors
Showing 1 to 15 of 39 entries

McKesson Corp(MCK-N) Rating

Ranking : 4 out of 5

Bullish - Buy Signals / Votes : 3

Neutral - Hold Signals / Votes : 0

Bearish - Sell Signals / Votes : 0

Total Signals / Votes : 3

Stockchase rating for McKesson Corp is calculated according to the stock experts' signals. A high score means experts mostly recommend to buy the stock while a low score means experts mostly recommend to sell the stock.

McKesson Corp(MCK-N) Frequently Asked Questions

What is McKesson Corp stock symbol?

McKesson Corp is a American stock, trading under the symbol MCK-N on the New York Stock Exchange (MCK). It is usually referred to as NYSE:MCK or MCK-N

Is McKesson Corp a buy or a sell?

In the last year, 3 stock analysts published opinions about MCK-N. 3 analysts recommended to BUY the stock. 0 analysts recommended to SELL the stock. The latest stock analyst recommendation is . Read the latest stock experts' ratings for McKesson Corp.

Is McKesson Corp a good investment or a top pick?

McKesson Corp was recommended as a Top Pick by on . Read the latest stock experts ratings for McKesson Corp.

Why is McKesson Corp stock dropping?

Earnings reports or recent company news can cause the stock price to drop. Read stock experts’ recommendations for help on deciding if you should buy, sell or hold the stock.

Is McKesson Corp worth watching?

3 stock analysts on Stockchase covered McKesson Corp In the last year. It is a trending stock that is worth watching.

What is McKesson Corp stock price?

On 2023-12-01, McKesson Corp (MCK-N) stock closed at a price of $464.65.